Dr. Chou's research laboratory investigates the mechanisms of normal hematopoietic development and how these become disrupted in hematologic diseases. Her laboratory primarily uses induced pluripotent stem cells and primary human cells to model blood diseases and study their underlying pathophysiology. They specifically focus on erythro-megakaryocytic development and the role of genetic modifiers in anemia, thrombocytopenia, and myeloproliferative disorders.

Dr. Chou's other research focus is alloimmunization in patients with sickle cell disease. Her research has demonstrated that transfusion of patients with sickle cell disease using African American donor units and antigen matched for D, C, E, and K did not reduce Rh alloimmunization and many Rh antibodies were explained by inheritance of variant RH genes.

Her current work focuses on alloimmunization prevention and transfusion safety for patients with sickle cell disease using genomics to identify risk of alloantibody formation and selecting compatible blood donors.

BA, Duke University (History), 1995

MD, New York Medical College, 2000

Fellowship, Children's Hospital of Philadelphia (Hematology/Oncology), 2006

Fellowship, Hospital of the University of Pennsylvania (Transfusion Medicine), 2010

Attending Physician

Associate Professor of Pediatrics

American Society of Hematology, 2004-

American Society of Pediatric Hematology/Oncology, 2005-

American Association of Blood Banks, 2008-

The American Society of Clinical Oncology Young Investigator Award, 2006

The Hope Street Kids Foundation Grant Award Fellow Award, 2006

The Leukemia and Lymphoma Society Fellow Award, 2006

National Blood Foundation Young Investigator Scholarship, 2011

National Blood Foundation Hall of Fame, 2018

Center for Childhood Cancer Research Profile